These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21211688)

  • 1. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators.
    Santini M; Gasparini M; Landolina M; Lunati M; Proclemer A; Padeletti L; Catanzariti D; Molon G; Botto GL; La Rocca L; Grammatico A; Boriani G;
    J Am Coll Cardiol; 2011 Jan; 57(2):167-72. PubMed ID: 21211688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term retention of cardiac resynchronization therapy.
    Knight BP; Desai A; Coman J; Faddis M; Yong P
    J Am Coll Cardiol; 2004 Jul; 44(1):72-7. PubMed ID: 15234410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.
    Yannopoulos D; Lurie KG; Sakaguchi S; Milstein S; Ermis C; VanHeel L; Benditt DG
    J Am Coll Cardiol; 2007 Sep; 50(13):1246-51. PubMed ID: 17888841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic capabilities of devices for cardiac resynchronization therapy.
    Gardini A; Lupo P; Zanelli E; Bisetti S; Cappato R
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):186-9. PubMed ID: 19829134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure Trial.
    Wilton SB; Exner DV; Wyse DG; Yetisir E; Wells G; Tang AS; Healey JS
    Circ Arrhythm Electrophysiol; 2016 May; 9(5):. PubMed ID: 27162033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
    Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
    Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
    Ansalone G; Ricci R; Cacciatore G; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
    Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrical storm in patients with biventricular implantable cardioverter defibrillator: incidence, predictors, and prognostic implications.
    Gasparini M; Lunati M; Landolina M; Santini M; Padeletti L; Perego G; Vincenti A; Curnis A; Carboni A; Denaro A; Spotti A; Grammatico A; Regoli F; Boriani G;
    Am Heart J; 2008 Nov; 156(5):847-54. PubMed ID: 19061697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of atrial tachyarrhythmias in patients treated by cardiac resynchronization (from the Prospective, Multicenter Mona Lisa Study).
    Marijon E; Jacob S; Mouton E; Defaye P; Piot O; Delarche N; Dennetiere S; Galley D; Le Franc P; Appl U; Guyomar Y; Albenque JP; Chevalier P; Boveda S;
    Am J Cardiol; 2010 Sep; 106(5):688-93. PubMed ID: 20723647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
    Borleffs CJ; van Rees JB; van Welsenes GH; van der Velde ET; van Erven L; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2010 Mar; 55(9):879-85. PubMed ID: 20185038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute hemodynamic effects of biventricular and left ventricular pacing in chronic pacemaker-dependent patients with advanced heart failure].
    Hansen C; Sperzel J; Neumann T; Pitschner HF; Neuzner J
    Z Kardiol; 2003 Oct; 92(10):862-8. PubMed ID: 14579051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure.
    Davis DR; Krahn AD; Tang AS; Lemery R; Green MS; Gollob M; Yee R; Skanes AC; Klein GJ; Birnie DH
    Can J Cardiol; 2005 Apr; 21(5):413-7. PubMed ID: 15861258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.